Listar por autor "Gabeta, S."
Mostrando ítems 1-18 de 18
-
Autoimmune hepatitis natural history: a single Greek center experience focused on long-term effect of mycophenolate mofetil as first line treatment
Zachou, K.; Gatselis, N.; Gabeta, S.; Saitis, A. I.; Papadamou, G.; Rigopoulou, E. I.; Koukoulis, G. K.; Dalekos, G. N. (2013) -
Cartilage oligomeric matrix protein (COMP) serum levels: a new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis
Gabeta, S.; Zachou, K.; Shums, Z.; Gatselis, N.; Koukoulis, G. K.; Norman, G. L.; Dalekos, G. N. (2014) -
CLINICAL SIGNIFICANCE OF THE FLUCTUATION OF PRIMARY BILIARY CIRRHOSIS-RELATED AUTOANTIBODIES DURING THE COURSE OF THE DISEASE
Gatselis, N. K.; Zachou, K.; Norman, G. L.; Gabeta, S.; Koukoulis, G. K.; Dalekos, G. N. (2012) -
Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease
Gatselis, N. K.; Zachou, K.; Norman, G. L.; Gabeta, S.; Papamichalis, P.; Koukoulis, G. K.; Dalekos, G. N. (2013)Primary biliary cirrhosis (PBC) is a chronic cholestatic disease characterized by the presence of antimitochondrial antibodies (AMA). PBC-specific antinuclear antibodies (ANA) have been characterized and associated with ... -
Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: A new or a complementary diagnostic score?
Gatselis, N. K.; Zachou, K.; Papamichalis, P.; Koukoulis, G. K.; Gabeta, S.; Dalekos, G. N.; Rigopoulou, E. I. (2010)Background and aims: The International Autoimmune Hepatitis Group developed a simplified score for autoimmune hepatitis. We assessed this "new scoring system" and compared it with the International Autoimmune Hepatitis ... -
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis
Gabeta, S.; Norman, G. L.; Liaskos, C.; Papamichalis, P. A.; Zografos, T.; Garagounis, A.; Rigopoulou, E. I.; Dalekos, G. N. (2007)Background/aims: Antimitochondrial antibodies (AMAs) are the serological hallmark of primary biliary cirrhosis (PBC). We evaluated the sensitivity and specificity of a new M2 enhanced performance enzyme-linked immunosorbent ... -
Down-regulation of hepcidin production in patients with autoimmune liver diseases
Gatselis, N.; Lyberopoulou, A.; Zachou, K.; Chachami, G.; Eliades, P.; Gabeta, S.; Paraskeva, E.; Mamalaki, A.; Koukoulis, G. K.; Simos, G.; Dalekos, G. N. (2014) -
Favourable outcome of life-threatening infectious-related haemophagocytic syndrome after combination treatment with corticosteroids and intravenous immunoglobulin infusions
Argyraki, C. K.; Gabeta, S.; Zachou, K.; Boulbou, M.; Polyzos, A.; Dalekos, G. N. (2011) -
Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat
Zachou, K.; Sarantopoulos, A.; Gatselis, N. K.; Vassiliadis, T.; Gabeta, S.; Stefos, A.; Saitis, A.; Boura, P.; Dalekos, G. N. (2013)AIM: To present the characteristics and the course of a series of anti- hepatitis B virus core antibody (HBc) antibody positive patients, who experienced hepatitis B virus (HBV) reactivation after immunosuppression. METHODS: ... -
IgA anti-b2GPI antibodies in patients with autoimmune liver diseases
Gabeta, S.; Norman, G. L.; Gatselis, N.; Liaskos, C.; Papamichalis, P. A.; Garagounis, A.; Zachou, K.; Rigopoulou, E. I.; Dalekos, G. N. (2008)Introduction Recently, we reported a high prevalence of immunoglobulin G and/or immunoglobulin M anticardiolipin antibodies (aCL) in patients with autoimmune liver diseases, namely, autoimmune hepatitis (AIH), primary ... -
IGA ANTIBODIES AGAINST DEAMIDATED GLIADIN PEPTIDES AND TISSUE-TRANSGLUTAMINASE IN PATIENTS WITH CHRONIC LIVER DISEASES
Gatselis, N. K.; Zachou, K.; Norman, G. L.; Tzelas, G.; Gabeta, S.; Speletas, M.; Koukoulis, G. K.; Dalekos, G. N. (2012) -
IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases
Gatselis, N. K.; Zachou, K.; Norman, G. L.; Tzellas, G.; Speletas, M.; Gabeta, S.; Germenis, A.; Koukoulis, G. K.; Dalekos, G. N. (2012)Background/aims: IgA antibodies against tissue-transglutaminase (anti-tTG-IgA) and IgA and IgG antibodies against deamidated gliadin peptides (anti-DGP-IgA and anti-DGP-IgG) are considered specific for celiac disease (CD) ... -
IgA isotype specific anti-b2GPI antibodies in patients with autoimmune liver diseases
Gabeta, S.; Norman, G. L.; Gatselis, N.; Liaskos, C.; Papamichalis, P. A.; Garagounis, A.; Zachou, K.; Rigopoulou, E. I.; Dalekos, G. N. (2008) -
Low Serum Hepcidin in Patients with Autoimmune Liver Diseases
Lyberopoulou, A.; Chachami, G.; Gatselis, N. K.; Kyratzopoulou, E.; Saitis, A.; Gabeta, S.; Eliades, P.; Paraskeva, E.; Zachou, K.; Koukoulis, G. K.; Mamalaki, A.; Dalekos, G. N.; Simos, G. (2015)Hepcidin, a liver hormone, is important for both innate immunity and iron metabolism regulation. As dysfunction of the hepcidin pathway may contribute to liver pathology, we analysed liver hepcidin mRNA and serum hepcidin ... -
Occult hepatitis B virus infection in patients with autoimmune liver diseases
Georgiadou, S. P.; Zachou, K.; Liaskos, C.; Gabeta, S.; Rigopoulou, E. I.; Dalekos, G. N. (2009)Occult hepatitis B virus (HBV) infection is characterized by undetectable serum HBV surface antigen (HBsAg) but detectable HBV-DNA in serum or liver. To determine the prevalence and clinical impact of occult HBV in autoimmune ... -
Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases
Zachou, K.; Liaskos, C.; Rigopoulou, E.; Gabeta, S.; Papamichalis, P.; Gatselis, N.; Georgiadou, S.; Dalekos, G. N. (2006)We studied the prevalence and clinical significance of anticardiolipin antibodies (aCL) in primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) as similar data are missing. Ninety-nine PBC patients, 41 ... -
Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients
Zografos, T. A.; Gatselis, N.; Zachou, K.; Liaskos, C.; Gabeta, S.; Koukoulis, G. K.; Dalekos, G. N. (2012)AIM: To determine the prevalence and significance of primary biliary cirrhosis (PBC)-specific autoantibodies in first-degree relatives (FDRS) of Greek PBC patients. METHODS: The presence of antimitochondrial antibodies ... -
The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders
Papamichalis, P. A.; Zachou, K.; Koukoulis, G. K.; Veloni, A.; Karacosta, E. G.; Kypri, L.; Mamaloudis, I.; Gabeta, S.; Rigopoulou, E. I.; Lohse, A. W.; Dalekos, G. N. (2007)Background. We conducted a study in order to determine the usefulness and diagnostic value of International Autoimmune Hepatitis Group (IAHG) score in non-autoimmune hepatitis (AIH) hepatic disorders as well as in AIH/overlap ...